Cerebral microbleeds in CADASIL

被引:195
作者
Oberstein, SAJL
van den Boom, R
van Buchem, MA
van Houwelingen, HC
Bakker, E
Vollebregt, E
Ferrari, MD
Breuning, MH
Haan, J
机构
[1] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands
[6] Rijnland Hosp, Dept Neurol, Leiden, Netherlands
关键词
D O I
10.1212/WNL.57.6.1066
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary arteriopathy leading to recurrent cerebral infarcts and dementia. Intracerebral hemorrhage (ICH) has been described sporadically in patients with CADASIL, suggesting that the affected arteries in CADASIL are not bleed-prone. However, the presence of cerebral microbleeds, which often remain undetected on conventional MRI, has not been determined in CADA-SIL. Objective: To determine whether cerebral vessels in patients with CADASIL are prone to microbleeding. Methods: T2*-weighted gradient echo MRI, which is highly sensitive for visualizing microbleeds, was performed in patients with CADASIL and their family members (n = 63). Known risk factors for ICH were determined for all individuals. On an exploratory basis, the presence of cerebral microbleeds was correlated with demographic variables, vascular risk factors, disease progression, ischemic I IR lesions, and genotype. Results: Cerebral microbleeds were present in 31% of symptomatic CADA-SIL mutation carriers, predominantly in the thalamus. Vascular risk factors such as hypertension did not account for the microbleeds in these patients. Factors associated with microbleeds were age (p = 0.008), Rankin disability score (p = 0.017), antiplatelet use (p = 0.025), number of lacunae on I IRI (p = 0.009), and the Arg153Cys Notch3 mutation (p 0.017). After correction for age, only the Arg153Cys mutation remained significantly associated with the presence of microbleeds. Conclusion: Patients with CADASIL have an age-related increased risk of intracerebral microbleeds. This implies that they may have an increased risk for ICH, which should be taken into account in CADASIL diagnosis and patient management.
引用
收藏
页码:1066 / 1070
页数:5
相关论文
共 19 条
[1]   AUTOSOMAL DOMINANT LEUKOENCEPHALOPATHY AND SUBCORTICAL ISCHEMIC STROKE - A CLINICOPATHOLOGICAL STUDY [J].
BAUDRIMONT, M ;
DUBAS, F ;
JOUTEL, A ;
TOURNIERLASSERVE, E ;
BOUSSER, MG .
STROKE, 1993, 24 (01) :122-125
[2]   HYPERTENSION AS A RISK FACTOR FOR SPONTANEOUS INTRACEREBRAL HEMORRHAGE [J].
BROTT, T ;
THALINGER, K ;
HERTZBERG, V .
STROKE, 1986, 17 (06) :1078-1083
[3]   Migraine with aura and white matter abnormalities:: Notch3 mutation [J].
Ceroni, M ;
Poloni, TE ;
Tonietti, S ;
Fabozzi, D ;
Uggetti, C ;
Frediani, F ;
Simonetti, F ;
Malaspina, A ;
Alimonti, D ;
Celano, M ;
Ferrari, M ;
Carrera, P .
NEUROLOGY, 2000, 54 (09) :1869-1871
[4]  
Fazekas F, 1999, AM J NEURORADIOL, V20, P637
[5]  
Franke CL, 1997, ANN NEUROL, V42, P857
[6]   Petechial hemorrhages accompanying lobar hemorrhage: Detection by gradient-echo MRI [J].
Greenberg, SM ;
Finklestein, SP ;
Schaefer, PW .
NEUROLOGY, 1996, 46 (06) :1751-1754
[7]  
Joutel A, 1998, NEUROLOGY, V50, pA441
[8]   Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia [J].
Joutel, A ;
Corpechot, C ;
Ducros, A ;
Vahedi, K ;
Chabriat, H ;
Mouton, P ;
Alamowitch, S ;
Domenga, V ;
Cecillion, M ;
Marechal, E ;
Maciazek, J ;
Vayssiere, C ;
Cruaud, C ;
Cabanis, EA ;
Ruchoux, MM ;
Weissenbach, J ;
Bach, JF ;
Bousser, MG ;
TournierLasserve, E .
NATURE, 1996, 383 (6602) :707-710
[9]   PROGRESS REVIEWS - INTRACEREBRAL HEMORRHAGE - NON-HYPERTENSIVE CAUSES [J].
KASE, CS .
STROKE, 1986, 17 (04) :590-595
[10]   Silent intracerebral microhemorrhages in patients with ischemic stroke [J].
Kwa, VIH ;
Franke, CL ;
Verbeeten, B ;
Stam, J .
ANNALS OF NEUROLOGY, 1998, 44 (03) :372-377